XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Schedule of Equity Award Activity (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Outstanding
stock
options    
Beginning balance (in shares) | shares 9,307,142  
Options granted (in shares) | shares 0  
Options exercised (in shares) | shares (2,135,767)  
Options canceled (in shares) | shares (287,388)  
Ending balance (in shares) | shares 6,883,987 9,307,142
Vested and exercisable (in shares) | shares 6,283,883  
Vested and expected to vest (in shares) | shares 6,883,987  
Weighted-
average
exercise
Price    
Beginning balance (USD per share) | $ / shares $ 6.41  
Options granted (USD per share) | $ / shares 0  
Options exercised (USD per share) | $ / shares 2.97  
Options canceled (USD per share) | $ / shares 14.12  
Ending balance (USD per share) | $ / shares 7.16 $ 6.41
Vested and exercisable (USD per share) | $ / shares 6.46  
Vested and expected to vest (usd per share) | $ / shares $ 7.16  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding, Weighted-average remaining contractual life (in years) 5 years 25 days 5 years 6 months 25 days
Vested and exercisable, Weighted-average remaining contractual life (in years) 4 years 10 months 20 days  
Vested and expected to vest, Weighted-average remaining contractual life (in years) 5 years 25 days  
Options outstanding, Aggregate intrinsic value | $ $ 15,150 $ 31,250
Vested and exercisable, Aggregate intrinsic value | $ 15,017  
Vested and expected to vest, Aggregate intrinsic value | $ $ 15,150